Jahnavi Sarma
... Read More
Hypoxia's ability to quietly inflict damage is why it's been coined "silent."
With the COvID-19 pandemic continuing unabated across the world, scientists are having a tough time trying to solve the many puzzling aspects of how the virus causing the deadly disease attacks the lungs and other parts of the body. One of the biggest and most life-threatening mysteries that emerged is how the virus causes "silent hypoxia," a condition when oxygen levels in the body are abnormally low. This causes irreparably damage to vital organs over time. But now, thanks to computer models and comparisons with real patient data, Boston University biomedical engineers and collaborators from the University of Vermont have begun to crack the mystery.
Despite experiencing dangerously low levels of oxygen, many people infected with severe cases of COVID-19 sometimes show no symptoms of shortness of breath or difficulty breathing. Hypoxia's ability to quietly inflict damage is why it's been coined "silent." In coronavirus patients, it's thought that the infection first damages the lungs, rendering parts of them incapable of functioning properly. Those tissues lose oxygen and stop working, no longer infusing the blood stream with oxygen, causing silent hypoxia. But exactly how that domino effect occurs has not been clear until now.
Initially researchers were not sure how this happens. Some coronavirus patients have experienced what some experts have described as levels of blood oxygen that are "incompatible with life." Disturbingly, many of these patients showed little to no signs of abnormalities when they underwent lung scans. To help get to the bottom of what causes silent hypoxia, BU biomedical engineers used computer modeling to test out three different scenarios that help explain how and why the lungs stop providing oxygen to the bloodstream. Their research, which has been published in Nature Communications, reveals that silent hypoxia is likely caused by a combination of biological mechanisms that may occur simultaneously in the lungs of COVID-19 patients.
Normally, the lungs perform the life-sustaining duty of gas exchange, providing oxygen to every cell in the body as we breathe in and ridding us of carbon dioxide each time we exhale. Healthy lungs keep the blood oxygenated at a level between 95 and 100 per cent -- if it dips below 92 per cent, it's a cause for concern and a doctor might decide to intervene with supplemental oxygen. The researchers first looked at how COVID-19 impacts the lungs' ability to regulate where blood is directed. Normally, if areas of the lung aren't gathering much oxygen due to damage from infection, the blood vessels will constrict in those areas. This is actually a good thing that our lungs have evolved to do, because it forces blood to instead flow through lung tissue replete with oxygen, which is then circulated throughout the rest of the body.
But preliminary clinical data have suggested that the lungs of some COVID-19 patients had lost the ability of restricting blood flow to already damaged tissue, and in contrast, were potentially opening up those blood vessels even more -- something that is hard to see or measure on a CT scan.
The findings suggest that a combination of all three factors are likely to be responsible for the severe cases of low oxygen in some COVID-19 patients. By having a better understanding of these underlying mechanisms, and how the combinations could vary from patient to patient, clinicians can make more informed choices about treating patients using measures like ventilation and supplemental oxygen. A number of interventions are currently being studied, including a low-tech intervention called prone positioning that flips patients over onto their stomachs, allowing for the back part of the lungs to pull in more oxygen and evening out the mismatched air-to-blood ratio. Since, different people respond to this virus so differently, it's critical to understand all the possible reasons why a patient's blood oxygen might be low, so that a proper form of treatment, including medications that could help constrict blood vessels, bust blood clots, or correct a mismatched air-to-blood flow ratio, can be decided on.
(With inputs from Agencies)